Nepa Gene's NEPA21 patented pulsing technology combines low voltage short-and-long pulses and reversing polarities, makes it possible to achieve high transfection efficiency and viability over a huge variety of cells, tissues, and even whole organisms.

NEPA21 novel 4-step pulse with voltage decay results in higher transfection efficiency and higher viability WITHOUT special buffers for difficult-to-transfect cells such as primary cells, stem cells, immune cells, blood cells, etc.